One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Management of EGFR-Variant and ALK-Positive Non-Small Cell Lung Cancer Brain Metastasis.
Toward a New Paradigm in Cancer Control-Integrating Individual and Population Approaches.
There Is Nothing Benign About Reducing the Cancer Research Budget.
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy.
Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2-Positive Locally Advanced Resectable Gastric Cancer: A Randomized Clinical Trial.
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.
Patient-Centered Research Through Artificial Intelligence to Identify Priorities in Cancer Care.
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury.
National Cancer System Characteristics and Global Pan-Cancer Outcomes.
Prognostic and Predictive Insights From Genomic Assays for Breast Cancer in Diverse Populations: A Review.
Changes in Oncology Medication Use After Withdrawal of Accelerated Approval.
Representation of the Middle East and North African Region in Oncology Clinical Trials.
Local Control and Extended Survival in Locally Advanced Hepatocellular Carcinoma.
Local Control and Extended Survival in Locally Advanced Hepatocellular Carcinoma.
Local Control and Extended Survival in Locally Advanced Hepatocellular Carcinoma-Reply.
Comments on a Modified Classification for Immunotherapy in Progressive Diseases.
Comments on a Modified Classification for Immunotherapy in Progressive Diseases-Reply.
